Endothelial Permeability and the Angiopoietin/Tie2 System Following Mild and Severe COVID-19
Lists
Only you see this
Abstract
Abstract Endotheliopathy plays a role in the development of acute kidney and lung injury in COVID-19, probably due to inflammation, endothelial permeability, vascular leakage and edema formation. This study examined alterations in the circulation of patients with mild and severe COVID-19 on in vitro endothelial permeability and its relation to the endothelial angiopoietin/Tie2 system, which is involved in the regulation of endothelial permeability. Plasma was obtained from COVID-19 patients admitted to the ward ( n = 14) or ICU ( n = 20) at admission and after 1 and 2 weeks and healthy controls ( n = 5). Human kidney and lung endothelial cells were exposed to patient plasma and treated with recombinant angiopoietin-1. In vitro endothelial barrier function was assessed using electric cell-substrate impedance sensing. Circulating markers of the angiopoietin/Tie2 system, endothelial dysfunction and glycocalyx degradation were measured by ELISA. Plasma from COVID-19 patients reduced endothelial resistance compared to healthy controls, but COVID-19 plasma-induced drop in endothelial resistance did not differ between ward and ICU patients. Circulating angiopoietin-2, soluble Tie2 and soluble Tie1 levels increased over time in ICU patients, whereas levels remained stable in ward patients. The increase in angiopoietin-2 was able to predict 90-day mortality (AUC = 0.914, p < 0.001). Treatment with recombinant angiopoietin-1 did not restore COVID-19 plasma-induced hyperpermeability. In conclusion, these results suggest that indirect effects of the virus represented in the circulation of COVID-19 patients induced endothelial hyperpermeability irrespective of disease severity and changes in the endothelial angiopoietin/Tie2 system. Nonetheless, angiopoietin-2 might be of interest in the context of organ injury and patient outcome in COVID-19.
BibTeX
@inproceedings{volleman2023endothelial,
author = {Carolien Volleman and Roselique Ibelings and Alexander P. J. Vlaar and Charissa E. van den Brom and Michiel A. van Agtmael and Anna Geke Algera and Rombout Van Amstel and Brent Appelman and Frank E.H.P. van Baarle and Diane Bax and Martijn Beudel and Harm‐Jan Boogaard and Marije K. Bomers and Peter I. Bonta and Lieuwe D. J. Bos and Michela Botta and John de Brabander and Godelieve J. de Bree and Sytze de Bruin and Marianna Bugiani and Dennis R. Buis and Esther Bulle and Osoul Chouchane and Alex Cloherty and Maurits C. F. J. de Rotte and Maartje Dijkstra and Dave A. Dongelmans and Romein W. G. Dujardin and Paul Elbers and Lucas M. Fleuren and Suzanne E. Geerlings and Teunis B. H. Geijtenbeek and Armand R. J. Girbes and Abraham Goorhuis and Martin P. Grobusch and Florianne Hafkamp and Laura A. Hagens and Jörg Hamann and Vanessa Harris and Robert Hemke and Sabine Hermans and Leo Heunks and Markus W. Hollmann and Janneke Horn and Joppe W. Hovius and M.C.M. de Jong and Rutger Koning and Endry H. T. Lim and Niels van Mourik and Diederik van de Beek and Esther J. Nossent and Frederique Paulus and Elma Peters and Dan Piña‐Fuentes and T vander Poll and Benedikt Preckel and Jan M. Prins and Jorinde Raasveld and Tom D. Y. Reijnders and Michiel Schinkel and Femke A. P. Schrauwen and Marcus J. Schultz and Alex R. Schuurman and Jaap Schuurmans and Kim Sigaloff and M. Slim and Patrick Smeele and Marry R. Smit and Cornelis Stijnis and Willemke Stilma and Charlotte E. Teunissen and Patrick Thoral and Anissa M. Tsonas and Pieter R. Tuinman and Margreeth Valk and Denise P. Veelo and Carolien Volleman and Henry J.C. de Vries and Lonneke A. van Vught and M. van Vugt and D. Wouters and Aeilko H. Zwinderman and Matthijs C. Brouwer and W. Joost Wiersinga and Alexander P. J. Vlaar and D van Beek and D van Beek},
title = {{Endothelial Permeability and the Angiopoietin/Tie2 System Following Mild and Severe COVID-19}},
booktitle = {Artery},
year = {2023},
doi = {10.1007/s44200-023-00036-2},
}